Discovery & Development

Analytical science has a key role to play in the development of new pharmaceutical products – from discovery, to protein analysis, to quality control.

A University of Buffalo team has produced a reverse vaccination to help manage the symptoms of various chronic and autoimmune conditions.

A wall of data stands between humankind and a revolution in our understanding of the body and its systems. AI can tear it down.

In this video interview, Mike Rea explains why each drug needs its own launch strategy.

A Korean team have conducted a study on a peptide that could help to produce medicines capable of crossing cell membranes and interfering with PPIs.

The way the pharma industry has traditionally handled clinical trials does not make participation easy.

Work at the Max Planck Institute of Molecular Physiology has revealed a welcome surprise: a potential new class of COVID-19 drugs.

A pill developed at MIT and inspired by tortoises could replace injections for monoclonal antibody therapies.

Emerging technologies are proving that small molecules aren't yesterday's news.

Meet the international coalition working to tackle COVID-19 in low- and middle-income countries.